United States Pharmaceuticals

Alimera Sciences Inc (ALIM)

Track

Ticker: ALIM Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Alimera Sciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 14 Sep 2023
Value US$4,908,786.82 | Price 83.27 | Shares 14,127 (+44.7%)
Sale 14 Sep 2023
Value US$972,464.68 | Price 10.79 | Shares 31,502 (+19.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-15 2023-09-14 B Purchase
3.6
Caligan Partners LP
Large shareholder
14,127 +44.7%
83.27
US$4,908,787 		14,127 +44.7% 83.27 US$4,908,787
2023-09-15 2023-09-14 S Sale
3.6
Caligan Partners LP
Large shareholder
31,502 +19.5%
10.79
US$972,465 		31,502 +19.5% 10.79 US$972,465
2023-05-19 2023-05-17 B Purchase
1.9
Morgan Adam
Non-Executive Director Large shareholder
89,140 -30.9%
434.16
US$3,390,032 		89,140 -30.9% 434.16 US$3,390,032
2023-03-28 2023-03-24 S Sale
0.5
Palo Alto Investors LP
Large shareholder
200,919 -100.0%
1.56
US$314,117 		200,919 -100.0% 1.56 US$314,117
2022-02-10 2022-02-08 S Sale
0.7
MORGAN STANLEY
Large shareholder
250,000 -31.0%
4.55
US$1,137,500 		250,000 -31.0% 4.55 US$1,137,500
2021-12-16 2021-12-15 B Purchase
2.6
EISWIRTH RICHARD S JR

President and CEO

Executive Director
484 +0.4%
4.50
US$2,177 		484 +0.4% 4.50 US$2,177
2021-12-07 2021-12-03 B Purchase
2.6
EISWIRTH RICHARD S JR

President and CEO

Executive Director
5,000 +4.8%
4.80
US$23,981 		5,000 +4.8% 4.80 US$23,981
2021-12-06 2021-12-02 B Purchase
2.6
EISWIRTH RICHARD S JR

President and CEO

Executive Director
5,000 +5.0%
4.89
US$24,428 		5,000 +5.0% 4.89 US$24,428
2021-11-08 2021-11-05 B Purchase
2.6
EISWIRTH RICHARD S JR

President and CEO

Executive Director
1,400 +1.4%
5.50
US$7,700 		1,400 +1.4% 5.50 US$7,700
2021-11-08 2021-11-04 B Purchase
2.6
EISWIRTH RICHARD S JR

President and CEO

Executive Director
10,086 +11.4%
4.41
US$44,446 		10,086 +11.4% 4.41 US$44,446
2021-11-04 2021-11-03 B Purchase
3.1
Holland David

Chief Marketing Officer & SVP

Officer
5,000 +19.1%
4.08
US$20,392 		5,000 +19.1% 4.08 US$20,392
2021-11-04 2021-11-03 B Purchase
2.6
EISWIRTH RICHARD S JR

President and CEO

Executive Director
28,005 +46.3%
4.45
US$124,745 		28,005 +46.3% 4.45 US$124,745
2021-11-04 2021-11-03 B Purchase
3.4
Largent James R
Non-Executive Director
10,000 +333.3%
4.31
US$43,090 		10,000 +333.3% 4.31 US$43,090
2021-11-04 2021-11-03 B Purchase
3.1
Jones John Philip

Chief Financial Officer

Officer
5,000 +25.0%
4.08
US$20,399 		5,000 +25.0% 4.08 US$20,399
2020-11-05 2020-11-04 B Purchase
2.5
Ashman Philip

Chief Operating Officer & SVP

Officer
1,316 +12.4%
4.50
US$5,922 		1,316 +12.4% 4.50 US$5,922
2020-11-04 2020-11-02 B Purchase
2.6
EISWIRTH RICHARD S JR

President and CEO

Executive Director
2,500 +6.3%
4.15
US$10,377 		2,500 +6.3% 4.15 US$10,377
2020-08-24 2020-08-20 S Sale
3.3
Myers C. Daniel
Non-Executive Director
5,000 -47.3%
6.73
US$33,650 		5,000 -47.3% 6.73 US$33,650
2019-12-11 2019-12-10 B Purchase Jones John Philip

Chief Financial Officer

Officer
1,000 +11.7%
9.29
US$9,294 		1,000 +11.7% 9.29 US$9,294
2019-11-25 2019-11-21 B Purchase Snisarenko John Non-Executive Director
10,000 +inf%
4.95
US$49,500 		10,000 +inf% 4.95 US$49,500
2019-11-20 2019-11-19 B Purchase
3.4
Largent James R
3,000 +inf%
5.11
US$15,344 		3,000 +inf% 5.11 US$15,344
2018-05-07 2018-05-07 B Purchase
2.6
EISWIRTH RICHARD S JR

President and CFO

Officer
10,000 +6.2%
1.05
US$10,500 		10,000 +6.2% 1.05 US$10,500
2018-02-09 2018-02-06 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-02-09 2018-02-06 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-02-09 2018-02-06 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
8,000 +0.1%
1.12
US$8,960 		8,000 +0.1% 1.12 US$8,960
2018-02-09 2018-02-05 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-02-09 2018-02-05 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-02-09 2018-02-05 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
4,000 +0.1%
1.14
US$4,560 		4,000 +0.1% 1.14 US$4,560
2018-02-09 2018-02-02 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-02-09 2018-02-02 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-02-09 2018-02-02 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
8,000 +0.1%
1.16
US$9,280 		8,000 +0.1% 1.16 US$9,280
2018-01-19 2018-01-19 S Sale
3.6
Green Kenneth

SVP & Chief Scientific Officer

Officer
5,404 -3.1%
1.18
US$6,378 		5,404 -3.1% 1.18 US$6,378
2018-01-19 2018-01-19 PlS Planned sale
2.5
Ashman Philip

SVP, EU Managing Director

Officer
12,750 -100.0%
1.18
US$15,048 		12,750 -100.0% 1.18 US$15,048
2018-01-19 2018-01-19 S Sale
2.6
EISWIRTH RICHARD S JR

President and CFO

Officer
6,809 -8.0%
1.18
US$8,036 		6,809 -8.0% 1.18 US$8,036
2018-01-19 2018-01-19 PlS Planned sale
3.1
Holland David

SVP of Sales and Marketing

Officer
12,750 -10.4%
1.18
US$15,048 		12,750 -10.4% 1.18 US$15,048
2018-01-19 2018-01-19 PlS Planned sale
2.3
Myers C. Daniel

CEO

Executive Director
26,450 -26.1%
1.18
US$31,216 		26,450 -26.1% 1.18 US$31,216
2018-01-19 2018-01-18 S Sale
3.6
Green Kenneth

SVP & Chief Scientific Officer

Officer
5,234 -2.9%
1.22
US$6,365 		5,234 -2.9% 1.22 US$6,365
2018-01-19 2018-01-18 PlS Planned sale
2.5
Ashman Philip

SVP, EU Managing Director

Officer
12,750 -50.0%
1.22
US$15,504 		12,750 -50.0% 1.22 US$15,504
2018-01-19 2018-01-18 S Sale
2.6
EISWIRTH RICHARD S JR

President and CFO

Officer
6,601 -7.2%
1.22
US$8,027 		6,601 -7.2% 1.22 US$8,027
2018-01-19 2018-01-18 PlS Planned sale
3.1
Holland David

SVP of Sales and Marketing

Officer
12,750 -9.4%
1.22
US$15,504 		12,750 -9.4% 1.22 US$15,504
2018-01-19 2018-01-18 PlS Planned sale
2.3
Myers C. Daniel

CEO

Executive Director
26,450 -20.7%
1.22
US$32,163 		26,450 -20.7% 1.22 US$32,163
2018-01-18 2018-01-17 S Sale
3.6
Green Kenneth

SVP & Chief Scientific Officer

Officer
5,739 -3.1%
1.23
US$7,065 		5,739 -3.1% 1.23 US$7,065
2018-01-18 2018-01-17 PlS Planned sale
2.3
Myers C. Daniel

CEO

Executive Director
26,450 -17.1%
1.23
US$32,560 		26,450 -17.1% 1.23 US$32,560
2018-01-18 2018-01-17 PlS Planned sale
2.5
Ashman Philip

SVP, EU Managing Director

Officer
12,750 -33.3%
1.23
US$15,695 		12,750 -33.3% 1.23 US$15,695
2018-01-18 2018-01-17 PlS Planned sale
3.1
Holland David

SVP of Sales and Marketing

Officer
12,750 -8.6%
1.23
US$15,695 		12,750 -8.6% 1.23 US$15,695
2018-01-18 2018-01-17 S Sale
2.6
EISWIRTH RICHARD S JR

President and CFO

Officer
7,239 -7.3%
1.23
US$8,911 		7,239 -7.3% 1.23 US$8,911
2018-01-18 2018-01-16 S Sale
3.6
Green Kenneth

SVP & Chief Scientific Officer

Officer
5,750 -3.0%
1.24
US$7,116 		5,750 -3.0% 1.24 US$7,116
2018-01-18 2018-01-16 PlS Planned sale
2.3
Myers C. Daniel

CEO

Executive Director
26,450 -14.6%
1.24
US$32,735 		26,450 -14.6% 1.24 US$32,735
2018-01-18 2018-01-16 PlS Planned sale
2.5
Ashman Philip

SVP, EU Managing Director

Officer
12,750 -25.0%
1.24
US$15,779 		12,750 -25.0% 1.24 US$15,779
2018-01-18 2018-01-16 PlS Planned sale
3.1
Holland David

SVP of Sales and Marketing

Officer
12,750 -7.9%
1.24
US$15,779 		12,750 -7.9% 1.24 US$15,779
2018-01-18 2018-01-16 S Sale
2.6
EISWIRTH RICHARD S JR

President and CFO

Officer
7,255 -6.9%
1.24
US$8,979 		7,255 -6.9% 1.24 US$8,979
2017-03-13 2017-03-10 S Sale
2.3
Myers C. Daniel

CEO

Executive Director
21,172 -10.5%
1.39
US$29,429 		21,172 -10.5% 1.39 US$29,429
2016-12-14 2016-12-12 S Sale
2.6
Roberts Calvin W.
Non-Executive Director
30,000 -31.3%
1.11
US$33,300 		30,000 -31.3% 1.11 US$33,300
2016-12-14 2016-12-12 S Sale
2.6
Roberts Calvin W.
Non-Executive Director
20,000 -20.9%
1.11
US$22,200 		20,000 -20.9% 1.11 US$22,200
2016-09-16 2016-09-15 PlS Planned sale
2.6
EISWIRTH RICHARD S JR

President and CFO

Officer
51,471 -59.5%
1.51
US$77,726 		51,471 -59.5% 1.51 US$77,726
2016-04-22 2016-04-21 PlS Planned sale BAVP, L.P. Large shareholder
700 -0.0%
5.15
US$3,605 		700 -0.0% 5.15 US$3,605
2016-04-22 2016-04-21 PlS Planned sale BAVP, L.P. Large shareholder
3,300 -0.1%
4.15
US$13,695 		3,300 -0.1% 4.15 US$13,695
2016-04-22 2016-04-21 PlS Planned sale BAVP, L.P. Large shareholder
20,703 -0.5%
3.35
US$69,355 		20,703 -0.5% 3.35 US$69,355
2016-04-22 2016-04-21 PlS Planned sale BAVP, L.P. Large shareholder
453,870 -10.1%
2.54
US$1,152,830 		453,870 -10.1% 2.54 US$1,152,830
2016-04-22 2016-04-20 PlS Planned sale BAVP, L.P. Large shareholder
100 -0.0%
2.02
US$202 		100 -0.0% 2.02 US$202
2015-12-17 2015-12-16 PlS Planned sale
2.6
EISWIRTH RICHARD S JR

COO and CFO

Officer
15,409 -30.6%
2.30
US$35,399 		15,409 -30.6% 2.30 US$35,399
2015-12-17 2015-12-15 PlS Planned sale
2.6
EISWIRTH RICHARD S JR

COO and CFO

Officer
31,260 -47.2%
2.32
US$72,520 		31,260 -47.2% 2.32 US$72,520
2015-12-08 2015-12-08 B Purchase Flynn James E Large shareholder
27,530 +3.9%
3.04
US$83,774 		27,530 +3.9% 3.04 US$83,774
2015-12-08 2015-12-08 B Purchase Flynn James E Large shareholder
27,529 +0.6%
3.04
US$83,771 		27,529 +0.6% 3.04 US$83,771
2015-12-08 2015-12-07 B Purchase Flynn James E Large shareholder
68,294 +10.8%
3.00
US$204,848 		68,294 +10.8% 3.00 US$204,848
2015-12-08 2015-12-07 B Purchase Flynn James E Large shareholder
68,294 +1.5%
3.00
US$204,848 		68,294 +1.5% 3.00 US$204,848
2015-12-08 2015-12-04 B Purchase Flynn James E Large shareholder
40,301 +6.8%
3.01
US$121,169 		40,301 +6.8% 3.01 US$121,169
2015-12-08 2015-12-04 B Purchase Flynn James E Large shareholder
40,301 +0.9%
3.01
US$121,169 		40,301 +0.9% 3.01 US$121,169
2015-12-03 2015-12-03 B Purchase Flynn James E Large shareholder
53,487 +9.9%
3.00
US$160,589 		53,487 +9.9% 3.00 US$160,589
2015-12-03 2015-12-03 B Purchase Flynn James E Large shareholder
53,486 +1.2%
3.00
US$160,586 		53,486 +1.2% 3.00 US$160,586
2015-12-03 2015-12-02 B Purchase Flynn James E Large shareholder
55,257 +11.4%
2.98
US$164,876 		55,257 +11.4% 2.98 US$164,876
2015-12-03 2015-12-02 B Purchase Flynn James E Large shareholder
55,257 +1.2%
2.98
US$164,876 		55,257 +1.2% 2.98 US$164,876
2015-12-03 2015-12-01 B Purchase Flynn James E Large shareholder
12,882 +2.7%
3.05
US$39,273 		12,882 +2.7% 3.05 US$39,273
2015-12-03 2015-12-01 B Purchase Flynn James E Large shareholder
12,883 +0.3%
3.05
US$39,276 		12,883 +0.3% 3.05 US$39,276
2015-11-10 2015-11-06 B Purchase Flynn James E Large shareholder
36,625 +8.4%
2.98
US$109,241 		36,625 +8.4% 2.98 US$109,241
2015-11-10 2015-11-06 B Purchase Flynn James E Large shareholder
36,625 +0.8%
2.98
US$109,241 		36,625 +0.8% 2.98 US$109,241
Explore more

More insider trading research around Alimera Sciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America